* Annovis Bio press release [https://seekingalpha.com/pr/20198633-annovis-provides-corporate-updates-and-reports-second-quarter-2025-financial-results] (NYSE:ANVS [https://seekingalpha.com/symbol/ANVS]): Q2 GAAP EPS of -$0.32 beats by $0.08.
* Annovis’ cash and cash equivalents totaled $17.1 million as of June 30, 2025, compared to $10.6 million as of December 31, 2024. The Company had 19.5 million shares of common stock outstanding as of June 30, 2025.
MORE ON ANNOVIS BIO
* Seeking Alpha’s Quant Rating on Annovis Bio [https://seekingalpha.com/symbol/ANVS/ratings/quant-ratings]
* Historical earnings data for Annovis Bio [https://seekingalpha.com/symbol/ANVS/earnings]
* Financial information for Annovis Bio [https://seekingalpha.com/symbol/ANVS/income-statement]
Annovis Bio GAAP EPS of -$0.32 beats by $0.08
Published 2 months ago
Aug 12, 2025 at 8:46 PM
Positive
Auto